| Literature DB >> 32669787 |
Abstract
Throughout the world, mental health remains a neglected priority, low on the agenda of policy makers and funders at the national and international levels. While this is shifting somewhat, there remains a considerable need to address the underprioritization of mental health and well-being, perhaps even more so in the wake of the COVID-19 pandemic. However, given the history of mental health interventions-which have overemphasized the biomedical model and have thus resulted in coercion, denial of life in the community, and unnecessary pathologization of human experience-there is also a need to ensure that increased funding does not simply replicate these mistakes. This is particularly true in the current landscape, where efforts to "scale up" mental health and to reduce "treatment gaps" are gaining momentum and where post-pandemic responses are still being formulated. As the potential for global mechanisms for funding mental health increases, national and international funders should look to practices that are rights affirming and contextually relevant. In this paper, I explore the current landscape of mental health financing, in terms of both national resource allocation and development assistance. I then outline the momentum in global mental health that is likely to materialize through increased funding, before considering ways in which that funding might be utilized in a manner that promotes human rights.Entities:
Mesh:
Year: 2020 PMID: 32669787 PMCID: PMC7348439
Source DB: PubMed Journal: Health Hum Rights ISSN: 1079-0969
Figure 1Total development assistance for mental health from all sources (in millions of US$)
Figure 2Destinations for development assistance for mental health (2017)
Largest funders for mental health interventions globally (2018)
| Australia | $51,106 |
| Bill and Melinda Gates Foundation | $1.4 million |
| Canada | $852,160 |
| France | $3.6 million |
| Germany | $9.5 million |
| Other | $29 million |
| United Nations | $9.4 million |
| Private foundations and corporate donors | $65.7 million |
| United Kingdom | $13.1 million |
| United States | $19.6 million |
Source: Institute for Health Metrics and Evaluation